Thermo Fisher Scientific Completes Acquisition of Viral Vector Manufacturing Business from Novasep for Approximately €725 Mil in Cash
The company notes that Novasep's viral vector manufacturing business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.